Shanghai HeartCare Medical Technology Corporation Limited (HKG:6609)

Market Cap	2.13B
Revenue (ttm)	367.02M
Net Income (ttm)	46.50M
Shares Out	37.98M
EPS (ttm)	1.22
PE Ratio	45.94
Forward PE	52.20
Dividend	n/a
Ex-Dividend Date	n/a

Volume	111,400
Average Volume	124,243
Open	52.70
Previous Close	50.70
Day's Range	52.70 - 57.85
52-Week Range	21.00 - 71.25
Beta	0.75
RSI	40.23
Earnings Date	Mar 25, 2026

About HKG:6609

Shanghai HeartCare Medical Technology Corporation Limited engages in the research and development, manufacture, and sale of neuro-interventional medical devices in Mainland China and internationally. It offers ischemic stroke thrombectomy devices, such as Captor Thrombectomy Stent, a thrombectomy stent retriever; aspiration catheter and pump; intracranial stenosis treatment devices, including intracranial drug-eluting balloon stent, embolization protection system, carotid artery stent, and intracranial balloon dilatation catheter and carotid ar...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2016
• Employees: 344
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 6609

Financial Performance

In 2024, HKG:6609's revenue was 277.90 million, an increase of 19.61% compared to the previous year's 232.34 million. Losses were -13.62 million, -85.51% less than in 2023.

Financial numbers in CNY